First Eagle Mid Cap Equity ETF
FEMD - ETF AI Analysis
Top Page
First Eagle Mid Cap Equity ETF (FEMD)
FEMD, the First Eagle Mid Cap Equity ETF, has a solid overall rating driven mainly by strong, diversified holdings in healthcare and financials such as GE Healthcare Technologies and Quest Diagnostics, which show robust financial performance, positive earnings calls, and supportive technical trends. Additional contributors like Tenet Healthcare, Steris, and Glacier Bancorp add to the fund’s quality through revenue growth, margin improvement, and sound balance sheets, though some holdings like Antero Resources and Cardinal Health face leverage and valuation concerns that slightly weigh on the rating. The main risk factor is exposure to companies with higher debt and potential overvaluation, which could increase volatility if market conditions worsen.
FEMD vs. SPDR S&P 500 ETF (SPY)
- AUM
- 3.99M
- Region
- North America
- Expense Ratio
- 0.55%
- Beta
- 0.68
- Issuer
- First Eagle
- Inception Date
- Jan 27, 2026
- Dividend Yield
- N/A
- Asset Class
- Equity
- Index Tracked
- No Underlying Index
FEMD Summary
First Eagle Mid Cap Equity ETF (FEMD) is an actively managed fund that focuses on medium‑sized U.S. companies, rather than tracking a fixed index. It spreads investments across many sectors, including industrials, financials, health care, energy, and technology. Well-known holdings include Workday and Phillips 66. Investors might consider FEMD if they want growth potential from mid-sized companies while adding diversification beyond large, blue-chip stocks. However, because it owns mid-cap stocks and is actively managed, its share price can move up and down more than the overall market, and there is no guarantee the managers’ picks will outperform.
How much will it cost me?
This ETF has an expense ratio of 0.55%, which means you’ll pay about $5.50 per year for every $1,000 invested. That’s higher than the average low-cost index ETF because this fund is actively managed, paying a team to research and select mid-cap stocks rather than just tracking an index.
What would affect this ETF?
This U.S. mid-cap ETF could benefit if the economy grows steadily, since many of its industrial and technology holdings tend to do well when businesses invest more and demand for equipment, software, and energy rises, giving active managers more chances to pick winners. On the downside, a weaker U.S. economy, higher interest rates, or tighter regulations on energy, financials, or industrial companies could hurt mid-sized firms more than large ones and weigh on this concentrated, actively managed portfolio.
FEMD Top 10 Holdings
FEMD leans heavily into U.S. mid-cap health care and energy names, with Tenet Healthcare and GE Healthcare acting as a tug-of-war: Tenet is rising on solid earnings while GE Healthcare has been lagging this year. On the energy side, Phillips 66 and Targa Resources have been steady to rising, giving the fund a sturdy backbone. SharkNinja adds a consumer twist with strong, rising momentum, while Glacier Bancorp has been more of a drag lately. Overall, performance is driven by a mix of defensive health care and cyclical energy, all squarely U.S.-focused.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 THC | Tenet Healthcare | 3.19% | $123.46K | $23.10B | 49.10% | 74Outperform |
 GEHC | GE Healthcare Technologies Inc | 3.04% | $117.50K | $37.82B | 13.84% | 78Outperform |
 STE | Steris | 2.65% | $102.66K | $24.97B | -2.61% | 77Outperform |
 GBCI | Glacier Bancorp | 2.57% | $99.50K | $6.35B | 14.91% | 74Outperform |
 DGX | Quest Diagnostics | 2.49% | $96.29K | $28.43B | 40.22% | 79Outperform |
 SN | SharkNinja, Inc. | 2.47% | $95.54K | $31.92B | 138.97% | 76Outperform |
 CAH | Cardinal Health | 2.39% | $92.67K | $63.98B | 34.74% | 66Neutral |
 BKH | Black Hills | 2.38% | $92.08K | $6.66B | 22.37% | 74Outperform |
 CP | Canadian Pacific Kansas City | ― | ― | ― | ― | 74Outperform |
 PFGC | Performance Food Group | 2.25% | $86.98K | $17.51B | 13.86% | 65Neutral |
FEMD Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FEMD, the sentiment is Positive. The current price of 36.18 is above the 20-day moving average (MA) of 35.35, above the 50-day MA of 34.99, and compared to the 200-day MA of , indicating a neutral trend. The MACD of 0.30 indicates Negative momentum. The RSI at 59.62 is Neutral, neither overbought nor oversold. The STOCH value of 54.57 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FEMD.
FEMD Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| FEMD | $36.18 | $38.00(5.02% Upside) | $3.99M | 0.55% | 70Neutral |
 KMID | $25.20 | $27.87(10.62% Upside) | $53.48M | 0.80% | 70Outperform |
 MMID | $27.76 | $31.28(12.68% Upside) | $37.75M | 0.59% | 68Neutral |
 SMCP | $26.24 | $28.96(10.39% Upside) | $13.64M | 0.79% | 71Outperform |
 TMID | $25.89 | $31.32(20.95% Upside) | $11.68M | 0.47% | 63Neutral |
 MCDS | $67.35 | $76.78(13.99% Upside) | $8.07M | 0.35% | 68Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| FEMD | First Eagle Mid Cap Equity ETF | 36.18 | 1.21 | 3.47% | |
| KMID | Virtus KAR Mid-Cap ETF | 25.20 | 1.09 | 4.50% | |
| MMID | MFS Active Mid Cap ETF | 27.76 | 3.09 | 12.50% | |
| SMCP | SMART Mid Cap ETF | 26.24 | 1.37 | 5.49% | |
| TMID | T. Rowe Price Mid Cap Equity Research ETF | 25.89 | 0.64 | 2.55% | |
| MCDS | JPMorgan Fundamental Data Science Mid Core ETF | 67.35 | 9.74 | 16.91% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.